Resultados de búsqueda - Lisa M. Cordes

  • Mostrando 1 - 15 Resultados de 15
Limitar resultados
  1. 1
    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review

    Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review por Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo

    Publicado 2021
    Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management

    Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management por Jaydira Del Rivero, Lisa M. Cordes, Joanna Kłubo-Gwieździńska, Ravi A. Madan, Lynnette K. Nieman, James L. Gulley

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

    Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors por Julius Strauss, Christopher R. Heery, Jeffrey Schlom, Ravi A. Madan, Liang Cao, Zhigang Kang, Elizabeth Lamping, Jennifer L. Marté, Renee N. Donahue, Italia Grenga, Lisa M. Cordes, Olaf Christensen, Lisa Mahnke, Christoph Helwig, James L. Gulley

    Publicado 2018
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury

    Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury por Christopher R. Heery, Claudia Palena, Sheri McMahon, Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Ulrike Dirmeier, Lisa M. Cordes, Jenn Marté, William L. Dahut, Harpreet Singh, Ravi A. Madan, Romaine I. Fernando, Duane H. Hamilton, Jeffrey Schlom, James L. Gulley

    Publicado 2017
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules

    A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules por Margaret E. Gatti‐Mays, Julius Strauss, Renee N. Donahue, Claudia Palena, Jaydira Del Rivero, Jason M. Redman, Ravi A. Madan, Jennifer L. Marté, Lisa M. Cordes, Elizabeth Lamping, Alanvin Orpia, Andrea Burmeister, Eva Wagner, Cesar Pico Navarro, Christopher R. Heery, Jeffrey Schlom, James L. Gulley

    Publicado 2019
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

    A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer por Margaret E. Gatti‐Mays, Jason M. Redman, Renee N. Donahue, Claudia Palena, Ravi A. Madan, Fatima Karzai, Marijo Bilušić, Houssein Abdul Sater, Jennifer L. Marté, Lisa M. Cordes, Sheri McMahon, Seth M. Steinberg, Alanvin Orpia, Andrea Burmeister, Jeffrey Schlom, James L. Gulley, Julius Strauss

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial por Christopher R. Heery, Geraldine O’Sullivan Coyne, Ravi A. Madan, Lisa M. Cordes, Arun Rajan, Myrna Rauckhorst, Elizabeth Lamping, Israel Oyelakin, Jennifer L. Marté, Lauren M. Lepone, Renee N. Donahue, Italia Grenga, Jean-Marie Cuillerot, Berend Neuteboom, Anja von Heydebreck, Kevin M. Chin, Jeffrey Schlom, James L. Gulley

    Publicado 2017
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer

    Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer por Houssein Abdul Sater, Jennifer L. Marté, Renee N. Donahue, Beatriz Walter-Rodriguez, Christopher R. Heery, Seth M. Steinberg, Lisa M. Cordes, Guinevere Chun, Fatima Karzai, Marijo Bilušić, Stephanie A. Harmon, Barış Türkbey, Peter L. Choyke, Jeffrey Schlom, William L. Dahut, Ravi A. Madan, Peter A. Pinto, James L. Gulley

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer

    PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer por Charalampos S. Floudas, Meghali Goswami, Renee N. Donahue, Julius Strauss, Danielle M. Pastor, Jason M. Redman, Isaac Brownell, Evrim Türkbey, Seth M. Steinberg, Lisa M. Cordes, Jennifer L. Marté, Maheen Khan, Sheri McMahon, Elizabeth Lamping, Michell Manu, Manuk Manukyan, Douglas E. Brough, Amy Lankford, Caroline Jochéms, J Schlom, James L. Gulley

    Publicado 2025
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

    A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer por Jason M. Redman, Yo-Ting Tsai, Benjamin A. Weinberg, Renee N. Donahue, Shruti U. Gandhy, Margaret E. Gatti‐Mays, Houssein Abdul Sater, Marijo Bilušić, Lisa M. Cordes, Seth M. Steinberg, Jennifer L. Marté, Caroline Jochéms, Sunnie S. Kim, John L. Marshall, Sheri McMahon, Erica Redmond, Jeffrey Schlom, James L. Gulley, Julius Strauss

    Publicado 2022
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  11. 11
    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies por Julius Strauss, Margaret E. Gatti‐Mays, Byoung Chul Cho, Andrew G. Hill, Sébastien Salas, Edward F. McClay, Jason M. Redman, Houssein Abdul Sater, Renee N. Donahue, Caroline Jochéms, Elizabeth Lamping, Andrea Burmeister, Jennifer L. Marté, Lisa M. Cordes, Marijo Bilušić, Fatima Karzai, Laureen S. Ojalvo, Genevieve Jehl, Alex Rolfe, Christian S. Hinrichs, Ravi A. Madan, Jeffrey Schlom, James L. Gulley

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  12. 12
    Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations

    Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations por Fatima Karzai, David James VanderWeele, Ravi A. Madan, Helen Owens, Lisa M. Cordes, Amy Hankin, Anna Couvillon, E. Hitt Nichols, Marijo Bilušić, Michael L. Beshiri, Kathleen Kelly, Venkatesh Krishnasamy, Sunmin Lee, Min-Jung Lee, Akira Yuno, Jane B. Trepel, Maria J. Merino, Ryan Dittamore, Jennifer L. Marté, Renee N. Donahue, Jeffrey Schlom, Keith Killian, Paul S. Meltzer, Seth M. Steinberg, James L. Gulley, Jung Min Lee, William L. Dahut

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  13. 13
    Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

    Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial por Andrea B. Apolo, Rosa Nadal, Yusuke Tomita, Nicole N. Davarpanah, Lisa M. Cordes, Seth M. Steinberg, Liang Cao, Howard L. Parnes, Rene Costello, Maria J. Merino, Les Folio, Liza Lindenberg, Mark Raffeld, Jeffrey Lin, Min-Jung Lee, Sunmin Lee, Sylvia V. Alarcon, Akira Yuno, Nancy A. Dawson, Kimaada Allette, Arpita Singha Roy, Dinuka De Silva, Molly M. Lee, Tristan M. Sissung, William D. Figg, Piyush K. Agarwal, James R. Wright, Yang‐Min Ning, James L. Gulley, William L. Dahut, Donald P. Bottaro, Jane B. Trepel

    Publicado 2020
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  14. 14
    Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

    Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors por Andrea B. Apolo, Rosa Nadal, Daniel M. Girardi, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Seth M. Steinberg, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Guerrero Díaz, Marissa Mallek, Nicole N. Davarpanah, Rene Costello, Jane B. Trepel, Min-Jung Lee, Maria J. Merino, Mohammadhadi Bagheri, Paul Monk, William D. Figg, James L. Gulley, Piyush K. Agarwal, Vladimir Valera, Heather J. Chalfin, Jennifer Jones, Howard Streicher, James R. Wright, Yang‐Min Ning, Howard L. Parnes, William L. Dahut, Donald P. Bottaro, Primo N. Lara, Biren Saraiya, Sumanta K. Pal, Mark N. Stein, Amir Mortazavi

    Publicado 2020
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  15. 15
    Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors

    Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors por Andrea B. Apolo, Daniel M. Girardi, Scot A. Niglio, Rosa Nadal, Andre R. Kydd, Nicholas I. Simon, Lisa Ley, Lisa M. Cordes, Elias Chandran, Seth M. Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, N Sato, Liang Cao, Abdul Rouf Banday, Salah Boudjadi, Maria J. Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K. Agarwal, Heather J. Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William D. Figg, Howard L. Parnes, James L. Gulley, Biren Saraiya, Sumanta K. Pal, David I. Quinn, Mark N. Stein, Primo N. Lara, Donald P. Bottaro, Amir Mortazavi

    Publicado 2024
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: